259 related articles for article (PubMed ID: 3019543)
21. High level of beta-type transforming growth factor activity in human urine obtained from cancer patients.
Nishimura R; Okumura H; Noda K; Yasumitsu H; Umeda M
Jpn J Cancer Res; 1986 Jun; 77(6):560-7. PubMed ID: 3089989
[TBL] [Abstract][Full Text] [Related]
22. Transforming growth factor receptors in liver regeneration following partial hepatectomy in the rat.
Gruppuso PA; Mead JE; Fausto N
Cancer Res; 1990 Mar; 50(5):1464-9. PubMed ID: 2154324
[TBL] [Abstract][Full Text] [Related]
23. Molecular dynamics simulations of epidermal growth factor and transforming growth factor-alpha structures in water.
Watts CR; Lovas S; Murphy RF
Proteins; 1998 Nov; 33(3):396-407. PubMed ID: 9829698
[TBL] [Abstract][Full Text] [Related]
24. Epidermal growth factor (EGF)-like transforming growth factor (TGF) activity and EGF receptors in ovine fetal tissues: possible role for TGF in ovine fetal development.
Freemark M; Comer M
Pediatr Res; 1987 Nov; 22(5):609-15. PubMed ID: 3500450
[TBL] [Abstract][Full Text] [Related]
25. Growth factor-independent proliferation of rat mammary carcinoma cells by autocrine secretion of neu-differentiation factor/heregulin and transforming growth factor-alpha.
Ethier SP; Langton BC; Dilts CA
Mol Carcinog; 1996 Feb; 15(2):134-43. PubMed ID: 8599580
[TBL] [Abstract][Full Text] [Related]
26. Purification and biological properties of type beta transforming growth factor from mouse transformed cells.
Fernandez-Pol JA; Klos DJ; Grant GA
Cancer Res; 1986 Oct; 46(10):5153-61. PubMed ID: 3489522
[TBL] [Abstract][Full Text] [Related]
27. Purification and characterization of a novel transforming growth factor.
Halper J; Moses HL
Cancer Res; 1987 Sep; 47(17):4552-9. PubMed ID: 2887280
[TBL] [Abstract][Full Text] [Related]
28. Purification of a high molecular weight form of epidermal growth factor from urine of breast cancer patients.
Eckert K; Granetzny A; Fischer J; Grosse R
Biomed Biochim Acta; 1989; 48(1):111-20. PubMed ID: 2789043
[TBL] [Abstract][Full Text] [Related]
29. Elevation of transforming growth factor alpha and its relationship to the epidermal growth factor and alpha-fetoprotein levels in patients with hepatocellular carcinoma.
Yeh YC; Tsai JF; Chuang LY; Yeh HW; Tsai JH; Florine DL; Tam JP
Cancer Res; 1987 Feb; 47(3):896-901. PubMed ID: 2433030
[TBL] [Abstract][Full Text] [Related]
30. Antitumor effects and normal tissue toxicity of 111In-labeled epidermal growth factor administered to athymic mice bearing epidermal growth factor receptor-positive human breast cancer xenografts.
Chen P; Cameron R; Wang J; Vallis KA; Reilly RM
J Nucl Med; 2003 Sep; 44(9):1469-78. PubMed ID: 12960194
[TBL] [Abstract][Full Text] [Related]
31. The coupling between transforming growth factor-alpha and the epidermal growth factor receptor during rat liver regeneration.
Strömblad S; Andersson G
Exp Cell Res; 1993 Feb; 204(2):321-8. PubMed ID: 8440328
[TBL] [Abstract][Full Text] [Related]
32. Growth factor production by human colon carcinoma cell lines.
Anzano MA; Rieman D; Prichett W; Bowen-Pope DF; Greig R
Cancer Res; 1989 Jun; 49(11):2898-904. PubMed ID: 2541895
[TBL] [Abstract][Full Text] [Related]
33. Sarcoma growth factor (SGF): specific binding to epidermal growth factor (EGF) membrane receptors.
De Larco JE; Todaro GJ
J Cell Physiol; 1980 Feb; 102(2):267-77. PubMed ID: 6246130
[TBL] [Abstract][Full Text] [Related]
34. Identification of a 15,000-molecular-weight form of immunoreactive transforming growth factor alpha in extracts of porcine pituitary.
Riss TL; Sirbasku DA
J Cell Physiol; 1989 Feb; 138(2):393-404. PubMed ID: 2918041
[TBL] [Abstract][Full Text] [Related]
35. Mouse Balb/c3T3 cell mutant with low epidermal growth factor receptor activity: induction of stable anchorage-independent growth by transforming growth factor beta.
Kuratomi Y; Ono M; Yasutake C; Mawatari M; Kuwano M
J Cell Physiol; 1987 Jan; 130(1):51-7. PubMed ID: 3468117
[TBL] [Abstract][Full Text] [Related]
36. Transforming growth factor beta: potential autocrine growth inhibitor of estrogen receptor-negative human breast cancer cells.
Arteaga CL; Tandon AK; Von Hoff DD; Osborne CK
Cancer Res; 1988 Jul; 48(14):3898-904. PubMed ID: 3164252
[TBL] [Abstract][Full Text] [Related]
37. Assessment of biological activity of linear alpha-transforming growth factor and monospecific antibodies to alpha-transforming growth factor and linear alpha-transforming growth factor.
Hanauske AR; Buchok JB; Pardue RL; Muggia VA; Von Hoff DD
Cancer Res; 1986 Nov; 46(11):5567-70. PubMed ID: 3463415
[TBL] [Abstract][Full Text] [Related]
38. Characterization of autostimulatory and transforming growth factors from human melanoma cells.
Richmond A; Lawson DH; Nixon DW; Chawla RK
Cancer Res; 1985 Dec; 45(12 Pt 1):6390-4. PubMed ID: 3864531
[TBL] [Abstract][Full Text] [Related]
39. Fibronectin-associated transforming growth factor.
Fava RA; McClure DB
J Cell Physiol; 1987 May; 131(2):184-9. PubMed ID: 3495542
[TBL] [Abstract][Full Text] [Related]
40. Transforming growth factors in the urine of normal, pregnant, and tumor-bearing humans.
Twardzik DR; Sherwin SA; Ranchalis J; Todaro GJ
J Natl Cancer Inst; 1982 Oct; 69(4):793-8. PubMed ID: 6288992
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
